Comparing COVID-19 vaccines for their characteristics, efficacy and effectiveness against SARS-CoV-2 and variants of concern: a narrative reviewThibault Fiolet, Nathan Peiffer‐Smadja|Clinical Microbiology and Infection|2021Cited by 945
Remdesivir plus standard of care versus standard of care alone for the treatment of patients admitted to hospital with COVID-19 (DisCoVeRy): a phase 3, randomised, controlled, open-label trialFlorence Ader, Raphaël Clère-Jehl, Alpha Diallo et al.|The Lancet Infectious Diseases|2021Cited by 344
Neurologic manifestations associated with COVID-19: a multicentre registryElodie Meppiel, Thibault Fraisse, Nathan Peiffer‐Smadja et al.|Clinical Microbiology and Infection|2020Cited by 142